IRIS
ROSSI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.290
NA - Nord America 470
AS - Asia 466
SA - Sud America 34
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.275
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.221
US - Stati Uniti d'America 446
SG - Singapore 159
CN - Cina 109
VN - Vietnam 78
BD - Bangladesh 60
HK - Hong Kong 26
FR - Francia 23
BR - Brasile 20
CA - Canada 9
DE - Germania 7
FI - Finlandia 7
IN - India 6
NL - Olanda 6
AR - Argentina 5
GB - Regno Unito 5
JP - Giappone 5
ZA - Sudafrica 5
ID - Indonesia 4
MX - Messico 4
RU - Federazione Russa 4
MY - Malesia 3
PH - Filippine 3
PL - Polonia 3
UA - Ucraina 3
CH - Svizzera 2
CR - Costa Rica 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
PE - Perù 2
PY - Paraguay 2
TR - Turchia 2
UY - Uruguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
AU - Australia 1
BS - Bahamas 1
CY - Cipro 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SE - Svezia 1
SV - El Salvador 1
VI - Stati Uniti Isole Vergini 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.275
Salva come PNG Salva come JPEG
Città #
Genoa 1.021
Genova 572
Rapallo 304
Vado Ligure 237
Ashburn 94
San Jose 86
Singapore 82
Council Bluffs 28
Beijing 25
Hanoi 22
Hong Kong 21
Lauterbourg 21
Ho Chi Minh City 18
Milan 13
Los Angeles 11
St Louis 10
Bordighera 8
Helsinki 7
New York 7
Frankfurt am Main 6
Naples 6
Buffalo 5
Chicago 5
Da Nang 5
Rome 5
Johannesburg 4
Philadelphia 4
Santa Clara 4
Tianjin 4
Tokyo 4
Billings 3
Boardman 3
Bologna 3
City of London 3
Dhaka 3
Mexico City 3
Piscataway 3
São Paulo 3
Turin 3
Addis Ababa 2
Amsterdam 2
Ancona 2
Arlington 2
Asunción 2
Atlanta 2
Beinasco 2
Biên Hòa 2
Catania 2
Cerritos 2
Cincinnati 2
Endicott 2
Haiphong 2
Hollister 2
Jersey City 2
Kyiv 2
Lima 2
Modena 2
Moncalieri 2
Montreal 2
New Delhi 2
Newark 2
Phoenix 2
Pittsburgh 2
Portsmouth 2
San José 2
Tashkent 2
Tualatin 2
Verona 2
Villasanta 2
Warsaw 2
Alexandria 1
Algiers 1
Athens 1
Auberville 1
Avezzano 1
Baltimore 1
Bari 1
Baton Rouge 1
Bauru 1
Belle 1
Bellinzona 1
Bengaluru 1
Benito Juarez 1
Benoni 1
Bishkek 1
Brisbane 1
Burleson 1
Bình Dương 1
Bình Phước 1
Cagliari 1
Cairo 1
Camaçari 1
Camden 1
Campinas 1
Camporotondo Etneo 1
Can Tho 1
Cao Lanh 1
Cardito 1
Castries 1
Castrop-Rauxel 1
Totale 2.758
Salva come PNG Salva come JPEG
Nome #
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients 201
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer 181
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center 171
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients 169
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients 167
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study 163
Radiomic detection of EGFR mutations in NSCLC 161
Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab 152
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer 148
Liquid biopsy in non-small cell lung cancer: Highlights and challenges 143
Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients 141
Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer 135
CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine 135
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer 133
Platelets and their derived extracellular vesicles: The new generation of markers in non-small cell lung cancer management 130
The role of the immune metabolic prognostic index in patients with non-small cell lung cancer (Nsclc) in radiological progression during treatment with nivolumab 121
Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics 117
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer 116
Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds 116
Radiomic-based diagnostics in oncology: challenges toward clinical practice 110
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 108
Vinflunine for the treatment of non-small cell lung cancer 103
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer 91
Immunotherapy for resectable NSCLC: neoadjuvant/perioperative followed by surgery over surgery followed by adjuvant. Systematic review and meta-analysis with subgroup analyses 82
Prognostic relevance of circulating tumor cells and circulating cell-free DNA association in metastatic non-small cell lung cancer treated with nivolumab 63
Totale 3.357
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.991
article - articoli 12.991
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.982
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022213 19 8 6 10 13 18 1 39 23 26 17 33
2022/2023337 20 23 5 34 76 55 4 24 47 10 38 1
2023/2024223 3 16 3 27 20 40 29 23 12 17 7 26
2024/2025704 23 36 18 66 55 72 59 147 35 42 77 74
2025/20261.324 162 22 70 119 161 78 194 74 136 128 113 67
2026/2027140 140 0 0 0 0 0 0 0 0 0 0 0
Totale 3.357